Steven Cohen’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | – | Sell |
-176,560
| Closed | -$5.55M | – | 4027 |
|
|
2026
Q2 | $5.55M | Sell |
176,560
-249,305
| -59% | -$7.36M | 0.01% | 1689 |
|
|
2026
Q1 | $10.5M | Buy |
+425,865
| New | +$10.1M | 0.01% | 1212 |
|
|
2024
Q3 | – | Sell |
-618,296
| Closed | -$9.6M | – | 2039 |
|
|
2024
Q2 | $9.6M | Buy |
618,296
+200,370
| +48% | +$3.12M | 0.03% | 632 |
|
|
2024
Q1 | $6.66M | Sell |
417,926
-78,665
| -16% | -$1.19M | 0.02% | 874 |
|
|
2023
Q4 | $8.35M | Buy |
496,591
+300,280
| +153% | +$4.1M | 0.02% | 743 |
|
|
2023
Q3 | $2.29M | Buy |
+196,311
| New | +$2.63M | 0.01% | 1105 |
|
|
2023
Q2 | – | Sell |
-1,470
| Closed | -$24.4K | – | 2258 |
|
|
2023
Q1 | $24.4K | Buy |
+1,470
| New | +$24.3K | ﹤0.01% | 1942 |
|
|
2020
Q4 | – | Sell |
-50,000
| Closed | -$149K | – | 944 |
|
|
2020
Q3 | $149K | Buy |
+50,000
| New | +$196K | ﹤0.01% | 878 |
|
|
2017
Q2 | – | Sell |
-877,266
| Closed | -$1.71M | – | 853 |
|
|
2017
Q1 | $1.71M | Sell |
877,266
-1,395,550
| -61% | -$1.78M | 0.01% | 685 |
|
|
2016
Q4 | $2.39M | Sell |
2,272,816
-94,148
| -4% | -$108K | 0.02% | 545 |
|
|
2016
Q3 | $2.58M | Hold |
2,366,964
| – | – | 0.02% | 530 |
|
|
2016
Q2 | $1.68M | Buy |
2,366,964
+103,388
| +5% | +$83.3K | 0.01% | 580 |
|
|
2016
Q1 | $2.65M | Sell |
2,263,576
-13,347
| -0.6% | -$20.7K | 0.02% | 531 |
|
|
2015
Q4 | $5.58M | Buy |
2,276,923
+70,659
| +3% | +$202K | 0.05% | 395 |
|
|
2015
Q3 | $6.62M | Sell |
2,206,264
-1,257,541
| -36% | -$5.43M | 0.05% | 381 |
|
|
2015
Q2 | $14.3M | Sell |
3,463,805
-3,104,195
| -47% | -$12.4M | 0.1% | 265 |
|
|
2015
Q1 | $28.4M | Buy |
6,568,000
+3,068,000
| +88% | +$11.1M | 0.19% | 155 |
|
|
2014
Q4 | $10.4M | Buy |
+3,500,000
| New | +$9.6M | 0.07% | 319 |
|
Other funds holding CPRX
Steven Cohen's CPRX Position: Q3 2026 in Review
Steven Cohen sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 176,560 shares — an estimated $5.55M sold.
Steven Cohen first reported a position in CPRX in Q4 2014 and held it in 18 quarters. The position peaked at $28.4M in Q1 2015. 2 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.
- Steven Cohen reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- Steven Cohen sold 176,560 Catalyst Pharmaceutical shares in Q3 2026, an estimated $5.55M.
- Steven Cohen first reported a position in Catalyst Pharmaceutical in Q4 2014 and held it in 18 quarters.
- Steven Cohen's Catalyst Pharmaceutical position peaked at $28.4M in Q1 2015.
- 2 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.